AR101679A2 - Composiciones para el tratamiento antiviral combinado - Google Patents

Composiciones para el tratamiento antiviral combinado

Info

Publication number
AR101679A2
AR101679A2 ARP150102708A ARP150102708A AR101679A2 AR 101679 A2 AR101679 A2 AR 101679A2 AR P150102708 A ARP150102708 A AR P150102708A AR P150102708 A ARP150102708 A AR P150102708A AR 101679 A2 AR101679 A2 AR 101679A2
Authority
AR
Argentina
Prior art keywords
compositions
combinations
emtricitabine
amino
cis
Prior art date
Application number
ARP150102708A
Other languages
English (en)
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39817204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR101679(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of AR101679A2 publication Critical patent/AR101679A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Combinaciones terapéuticas de fumarato de diisopropoxicaraboniloximetil éster del ácido [2-(6-amino-purin-9-il)-1-metil-etoximetil]-fosfónico (tenofovir disoproxil fumarato, Viread®) y (2R,5S,cis)-4-amino-5-fluoro-1-(2-hidroximetil-1,3-oxatiolan-5-il)-(1H)-pirimidin-2-ona (emtricitabina, EmtrivaTM, (-)-cis FTC)) y sus derivados fisiológicamente funcionales. Las combinaciones pueden resultar de utilidad en el tratamiento de infecciones por VIH, incluso infecciones con mutantes del VIH que son resistentes a los inhibidores nucleósidos y no nucleósidos. Composiciones y formulaciones farmacéuticas de dichas combinaciones de tenofovir disoproxil fumarato y emtricitabina, y sus derivados fisiológicamente funcionales, como así también a métodos terapéuticos para usar estas composiciones y formulaciones.
ARP150102708A 2003-01-14 2015-08-24 Composiciones para el tratamiento antiviral combinado AR101679A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44024603P 2003-01-14 2003-01-14

Publications (1)

Publication Number Publication Date
AR101679A2 true AR101679A2 (es) 2017-01-04

Family

ID=39817204

Family Applications (2)

Application Number Title Priority Date Filing Date
AR20040100087A AR040805A1 (es) 2003-01-14 2004-01-14 Composiciones que contienen tenofovir y emtricitabina y metodos para terapia antiviral
ARP150102708A AR101679A2 (es) 2003-01-14 2015-08-24 Composiciones para el tratamiento antiviral combinado

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR20040100087A AR040805A1 (es) 2003-01-14 2004-01-14 Composiciones que contienen tenofovir y emtricitabina y metodos para terapia antiviral

Country Status (4)

Country Link
AR (2) AR040805A1 (es)
NO (1) NO20160777A1 (es)
TW (1) TWI355270B (es)
UA (1) UA81797C2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2665037C2 (ru) * 2016-12-12 2018-08-27 Общество с ограниченной ответственностью "Вириом" Изопропил N-[{ [(1R)-2-(6-амино-9H-пурин-9-ил)-1-метилэтокси]метил} (1,3-бензотиазол-6-ил-окси)фосфорил]-L-аланинат фумарат в качестве противовирусного препарата - пролекарства Тенофовира

Also Published As

Publication number Publication date
TWI355270B (en) 2012-01-01
AR040805A1 (es) 2005-04-20
TW200423946A (en) 2004-11-16
UA81797C2 (uk) 2008-02-11
NO20160777A1 (no) 2005-10-13

Similar Documents

Publication Publication Date Title
BRPI0406760A (pt) Composições e métodos para terapia antiviral de combinação
CY1124720T1 (el) Απο του στοματος σκευασματα αναλογων κυτιδινης και μεθοδοι χρησης αυτων
EA200970273A1 (ru) Применение 2-6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2н-пиримидин-1-илметил-4-фторбензонитрила
NI201300107A (es) Derivados de nucleósidos 2' - sustituidos y métodos de uso de los mismos para el tratamiento de enfermedades virales.
CY1124914T1 (el) Στερεες φαρμακευτικες συνθεσεις που περιεχουν αναστολεα ιντεγκρασης
NI201000050A (es) Derivados de pirrolo [2, 3-d] pirimidina como inhibidores de proteínas quinasas b.
ECSP099687A (es) Administración semanal de inhibidores de peptidasa de dipeptidilo
MX2009012433A (es) Azido nucleosidos de purina para el tratamiento de infecciones virales.
ECSP11011249A (es) Derivados de fosforamidato de compuestos nucleósidos de guanosina para el tratamiento de infecciones virales
PE20120602A1 (es) ATROPISOMEROS DE 2-[(6-AMINO-9H-PURIN-9-IL)METIL]-5-METIL-3-o-TOLILQUINAZOLIN-4(3H)-ONA
CL2012000917A1 (es) Compuestos derivados de pirazolo [3,4-d] pirimidina, inhibidores btk; y uso en el tratamiento del cancer, enfermedades autoinmune, mastocitosis,osteoporosis,entre otras.
CO2017004517A2 (es) Inhibidores de las tirosina cinasas de bruton derivados de la 2, 3, 4, 9-tetrahidro-ih-carbazol-8- carboxamida y 9h-carbazol-l-carboxamida, composiciones que los comprenden y metodos de elaboration
EA199700203A1 (ru) Синергические комбинации зидовудина, 1592u89 и 3тс или ftc
EA200800726A1 (ru) Введение ингибиторов дипептидилпептидазы
AR062522A1 (es) Tratamiento de desordenes en cartilagos
SG136123A1 (en) Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
RU2013148779A (ru) Лечение инфекции вируса гепатита в по отдельности или в комбинации с вирусом гепатита дельта и родственных заболеваний печени
NZ590075A (en) citrate, malonate and succinate salts of the HIV inhibitor ethyl N-[(S)({ [(2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl]oxy} methyl)phenoxyphosphinoyl]-L-alaninate
AR101679A2 (es) Composiciones para el tratamiento antiviral combinado
AR043332A1 (es) Composiciones y metodos para terapia antiviral
TR200101486T2 (tr) Antiviral kombinezonlar
NZ601519A (en) COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS INFECTION comprising lamivudine and adefovir dipivoxil
AR040242A1 (es) Composiciones farmaceuticas
AR026255A1 (es) Combinaciones antivirales.
CO2022000503A2 (es) Composiciones sólidas orales de liberación inmediata de múltiples unidades, métodos y usos de las mismas

Legal Events

Date Code Title Description
FB Suspension of granting procedure